• Tiamulin as a Small-Molecule TNF-α Inhibitor for Psoriasis M

  2026-06-03

  The reference study identifies Tiamulin fumarate as a potent small-molecule inhibitor of TNF-α, capable of blocking key inflammatory pathways involved in psoriasis. Its dual antibacterial and anti-inflammatory mechanisms suggest new research avenues for both dermatological and veterinary applications.

• H-Aggregated NIR-II Fluorophores Enhance Tumor-Targeted PTT

  2026-06-02

  Yu et al. developed a peptide-functionalized liposomal nanosystem that delivers H-aggregated NIR-II fluorophores to tumor cell membranes, enabling synergistic photothermal therapy (PTT) and chemotherapy with precise imaging. This approach addresses stability and efficiency challenges in organic fluorophore-mediated PTT and sets the stage for improved tumor-selective treatment platforms.

• DAF-2 Diacetate for Reliable Live-Cell Nitric Oxide Imaging

  2026-06-02

  DAF-2 diacetate empowers high-sensitivity, real-time nitric oxide detection in physiologically relevant systems, with robust performance in live-cell and in vivo workflows. This article explores advanced protocol optimization, troubleshooting, and unique insights from recent legume nodule research to maximize assay success.

• VP26–Host Cytoskeleton Interactions Govern DEV Proliferation

  2026-06-01

  This study identifies key host cytoskeletal proteins targeted by the duck enteritis virus (DEV) protein VP26, demonstrating that the actin–myosin II network, especially MYH9, is essential for viral replication. Functional inhibition of actin polymerization, including with Latrunculin A, significantly reduces DEV proliferation, highlighting the cytoskeleton as a critical antiviral target.

• Mtb Survival via BMX-Dependent ATP6V1E1 Phosphorylation Modu

  2026-06-01

  This study reveals how Mycobacterium tuberculosis (Mtb) evades host immune clearance by exploiting BMX kinase to phosphorylate and inhibit ATP6V1E1, a subunit critical for lysosomal acidification. These findings uncover a new host-pathogen interaction axis and suggest kinase inhibition as a potential host-directed therapy strategy.

• Lambda Protein Phosphatase: Accelerating Circadian Mechanism

  2026-05-31

  This article explores how Lambda Protein Phosphatase (RNase-free) from APExBIO is revolutionizing the mechanistic investigation of circadian clock proteins, especially BMAL1, by enabling precise and reproducible dephosphorylation workflows. We synthesize recent advances in phase separation–mediated regulation, highlight strategic guidance for translational researchers, and position λ-PPase as an essential tool for phosphorylation site validation and functional assay development.

• Erastin as a Precision Ferroptosis Inducer in Cancer Biology

  2026-05-30

  Erastin unlocks selective ferroptosis in RAS/BRAF-mutant tumors, enabling high-fidelity oxidative stress assays and radiosensitization studies. This guide details cutting-edge workflows, troubleshooting, and real-world insights drawn from peer-reviewed research and advanced applications.

• Methicillin Sodium Salt: Precision, Resistance, and Clinical

  2026-05-29

  Explore the role of Methicillin sodium salt in high-fidelity bacterial cell wall synthesis inhibition and translational research. This article reveals advanced protocol insights, resistance mechanisms, and cross-references cutting-edge clinical research for Staphylococcus aureus infection models.

• Tyrothricin: Mechanistic Leverage for Translational Infectio

  2026-05-29

  A deep dive into Tyrothricin’s broad-spectrum peptide antibiotic mechanisms, strategic deployment in translational research, and its potential to bridge infection studies with emerging redox biology and membrane-targeted therapeutics. This article provides advanced, actionable guidance for researchers seeking to optimize antimicrobial assays and understand the implications of membrane disruption across bacterial, fungal, and viral models.

• Rottlerin (SKU B6803): Reliable PKC Inhibition for Cell Assa

  2026-05-28

  This article addresses common challenges in cell viability and apoptosis assays by detailing how Rottlerin (SKU B6803) delivers reproducible, selective PKCδ inhibition. Drawing on peer-reviewed studies and practical lab scenarios, it demonstrates how this compound, supplied by APExBIO, supports rigorous mechanistic research and workflow optimization for biomedical scientists.

• AICAR: Applied Workflows for AMPK Activation in Metabolic Re

  2026-05-28

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) is a gold-standard, cell-permeable AMPK activator with proven utility in dissecting energy metabolism and inflammation in vitro and in vivo. This article translates cutting-edge reference findings into practical protocols, troubleshooting strategies, and workflow enhancements for metabolic disease and cellular stress research.

• Homoharringtonine: Cytotoxic Alkaloid Workflows for Cancer &

  2026-05-27

  Homoharringtonine, a cytotoxic alkaloid, stands out for its dual utility in both leukemia research and rapid SARS-CoV-2 clearance. This article unpacks validated experimental protocols, highlights recent breakthroughs, and delivers actionable troubleshooting insights for maximizing reproducibility and translational impact.

• Ibrutinib-Induced Atrial Fibrillation: Role of CSK Inhibitio

  2026-05-27

  This study identifies off-target inhibition of C-terminal Src kinase (CSK), not Bruton tyrosine kinase (BTK), as the principal driver of ibrutinib-induced atrial fibrillation (AF) in preclinical models. The findings clarify the mechanistic underpinnings of ibrutinib’s cardiac side effects and suggest that avoiding CSK inhibition could improve the safety profile of kinase inhibitors in oncology.

• Fluo-4 AM: Advanced Calcium Imaging for Cell Signaling Assay

  2026-05-26

  Fluo-4 AM empowers researchers to visualize real-time calcium dynamics with exceptional sensitivity, streamlining workflows in cell signaling and pharmacological assessment. Its robust performance and adaptability make it the go-to fluorescent calcium indicator for high-content and mechanistic studies.

• Redefining Protein Integrity: Next-Gen Protease Inhibitor Co

  2026-05-26

  This article explores how robust protease inhibitor cocktails underpin translational research by preserving protein integrity during extraction and analysis, with mechanistic insight drawn from recent oncology findings. It contextualizes the APExBIO Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) within emerging workflows, bridges evidence from colorectal cancer studies, and provides protocol guidance for optimal assay performance.

421 records 14/29 page Previous Next First page 上5页 1112131415 下5页 Last page